DAPAGLIFLOZIN

60512 reported adverse events

Drug classes: Sodium-Glucose Cotransporter 2 Inhibitor [EPC]

These side effects are most commonly reported by patients taking DAPAGLIFLOZIN:

# Side effect Count
0 DEATH 8511
1 FATIGUE 2672
2 NAUSEA 2619
3 DIARRHOEA 2478
4 DIZZINESS 2464
5 DYSPNOEA 2307
6 OFF LABEL USE 2128
7 WEIGHT DECREASED 2048
8 ACUTE KIDNEY INJURY 2047
9 BLOOD GLUCOSE INCREASED 2009
See all common reactions for DAPAGLIFLOZIN

DAPAGLIFLOZIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CARDIOSPASM 404 0.7240
1 IMMUNISATION 257 0.5922
2 PALMOPLANTAR KERATODERMA 394 0.5434
3 PRURITUS GENITAL 526 0.2232
4 ATRIAL TACHYCARDIA 406 0.1931
5 KETOSIS 205 0.1889
6 EUGLYCAEMIC DIABETIC KETOACIDOSIS 779 0.1885
7 CAROTID ARTERY OCCLUSION 411 0.1125
8 SLEEP TERROR 395 0.0937
9 TENSION HEADACHE 398 0.0925
See all enriched reactions for DAPAGLIFLOZIN